
|Articles|July 1, 2020
Supplements and Featured Publications
- Perspectives on the Value of Icosapent Ethyl
Perspectives on the Value of Icosapent Ethyl
Advertisement
This publication highlights key experts discussing the value of Vascepa® (icosapent ethyl).
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
Cefdinir Nearly Doubles Outpatient Uncomplicated UTI Treatment Failure Compared With Cephalexin
2
FDA Approves Ziftomenib for R/R NPM1-Mutated AML
3
Nipocalimab Investigation Extends to Younger Patients: Jonathan Strober, MD
4
Managed Care Reflections: A Q&A With Laurie C. Zephyrin, MD, MPH, MBA
5















































